Learn the essentials of CIAM for modern software development. Explore passwordless authentication, mfa, and how to scale user management securely.
Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback